Radiological Physics Characteristics of the Extracted Heavy Ion Beams of the Bevatron von Tobias, C. A., Lyman, J. T., Chatterjee, A., Howard, J., Maccabee, H. D., Raju, M. R., Smith, A. R., Sperinde, J. M., Welch, G. P.

Volltext

Wire spark chambers for clinical imaging of gamma-rays von Kaufman, L, Perez-Mendez, V, Rindi, A, Sperinde, J M, Wollenberg, H A

Volltext

Measurement of Radiative Pion-Proton Scattering near the Δ ( 1236 ) Resonance von Arman, M., Blasberg, D. J., Haddock, R. P., Leung, K. C., Nefkens, B. M. K., Schrock, B. L., Sober, D. I., Sperinde, J. M.

Volltext

Measurement of radiative pion-proton scattering at backward photon angles von Sober, D. I., Arman, M., Blasberg, D. J., Haddock, R. P., Leung, K. C., Nefkens, B. M. K., Schrock, B. L., Sperinde, J. M.

Volltext

Analyzing power and phase-shift analysis of proton-helium elastic scattering at 70 and 80 MeV von Perez-Mendez, V., Sperinde, J.M., Stetz, A.W.

Volltext

The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses von Pachynski, Russell K, Zabel, Brian A, Kohrt, Holbrook E, Tejeda, Nicole M, Monnier, Justin, Swanson, Christina D, Holzer, Alison K, Gentles, Andrew J, Sperinde, Gizette V, Edalati, Abdolhossein, Hadeiba, Husein A, Alizadeh, Ash A, Butcher, Eugene C

Volltext

Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers von GHOSH, Ritwik, NARASANNA, Archana, SPERINDE, Jeff, DUA, Rajiv, PIDAPARTHI, Sailaja, MUKHERJEE, Ali, LEITZEL, Kim, KOSTLER, Wolfgang J, LIPTON, Allan, BATES, Michael, ARTEAGA, Carlos L, WANG, Shizhen Emily, SHUYING LIU, CHAKRABARTY, Anindita, BALKO, Justin M, GONZALEZ-ANGULO, Ana Maria, MILLS, Gordon B, PENUEL, Elicia, WINSLOW, John

Volltext

Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10 von Abraham, Jame, Montero, Albert J, Jankowitz, Rachel C, Salkeni, Mohamad Adham, Beumer, Jan H, Kiesel, Brian F, Piette, Fanny, Adamson, Laura M, Nagy, Rebecca J, Lanman, Richard B, Sperinde, Jeff, Huang, Weidong, Allegra, Carmen J, Srinivasan, Ashok, Wang, Ying, Pogue-Geile, Katherine L, Lucas, Peter C, Jacobs, Samuel A

Volltext

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer von Lipton, Allan, Goodman, Laurie, Leitzel, Kim, Cook, Jennifer, Sperinde, Jeff, Haddad, Mojgan, Köstler, Wolfgang J., Huang, Weidong, Weidler, Jodi M., Ali, Suhail, Newton, Alicia, Fuchs, Eva-Marie, Paquet, Agnes, Singer, Christian F., Horvat, Reinhard, Jin, Xueguang, Banerjee, Joyee, Mukherjee, Ali, Tan, Yuping, Shi, Yining, Chenna, Ahmed, Larson, Jeff, Lie, Yolanda, Sherwood, Thomas, Petropoulos, Christos J., Williams, Stephen, Winslow, John, Parry, Gordon, Bates, Michael

Volltext

Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases von Duchnowska, Renata, Sperinde, Jeff, Chenna, Ahmed, Huang, Weidong, Weidler, Jodi M, Winslow, John, Haddad, Mojgan, Paquet, Agnes, Lie, Yolanda, Trojanowski, Tomasz, Mandat, Tomasz, Kowalczyk, Anna, Czartoryska-Arłukowicz, Bogumiła, Radecka, Barbara, Jarosz, Bożena, Staszkiewicz, Rafal, Kalinka-Warzocha, Ewa, Chudzik, Małgorzata, Biernat, Wojciech, Jassem, Jacek

Volltext

Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab von Bates, M., Sperinde, J., Köstler, W.J., Ali, S.M., Leitzel, K., Fuchs, E.M., Paquet, A., Lie, Y., Sherwood, T., Horvat, R., Singer, C.F., Winslow, J., Weidler, J.M., Huang, W., Lipton, A.

Volltext

Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients von SPERINDE, Jeff, XUEGUANG JIN, FUCHS, Eva-Maria, SINGER, Christian F, KÖSTLER, Wolfgang J, BATES, Michael, PARRY, Gordon, WINSLOW, John, LIPTON, Allan, BANERJEE, Jayee, PENUEL, Elicia, SAHA, Anasuya, DIEDRICH, Gundo, WEIDONG HUANG, LEITZEL, Kim, WEIDLER, Jodi, ALI, Suhail M

Volltext

Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonism von Schauer, Stephen P., Cho, Chang Hoon, Novikova, Gloriia, Roth, Gillie A., Lee, Julie, Sharma, Anup D., Foley, Alejandro R., Ng, Carl, Shen, Philip, Choi, Meena, Ma, Taylur P., Phu, Lilian, Budayeva, Hanna G., Cheung, Tommy K., Lalehzadeh, Guita, Imperio, Jose, Ngu, Hai, Etxeberria, Ainhoa, Liang, Yuxin, Rezzonico, Mitchell G., Dourado, Michelle, Huang, Kevin, Lai, Zijuan, Hokom, Martha, Pandya, Nikhil J., Newton, Dwight, Abdel‐Haleem, Alyaa M., Chan, Pamela, Lee, Donna, Tassew, Nardos G., Sangaraju, Dewakar, O'Connor, Deborah, Hötzel, Isidro, Stark, Kimberly L., Chou, Carolina, Foreman, Oded, Easton, Amy, Wildsmith, Kristin R., Sperinde, Gizette, Rose, Christopher M., Friedman, Brad A., Fuji, Reina N., Weimer, Robby M., Meilandt, William J., Sadekar, Shraddha, Nugent, Alicia A., Biever, Anne

Volltext

Abstract P1-03-02: ASCO/CAP human epidermal growth factor receptor-2 (HER2) in situ hybridization (ISH) categories evaluated by quantitative HER2 protein diagnostic methodologies:... von Buscaglia, B, Turner, B, Goda, H, Huang, W, Leitzel, K, Natori, T, Nakano, Y, Okada, H, Sperinde, J, Ali, S, Vasekar, M, D'Aguiar, M, McMahon, L, Henry, J, Lipton, A, Hicks, D

Volltext

A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer von Tolaney, S.M., Najita, J., Sperinde, J., Huang, W., Chen, W.Y., Savoie, J., Fornier, M., Winer, E.P., Bunnell, C., Krop, I.E.

Volltext

Very high quantitative tumor HER2 content and outcome in early breast cancer von Joensuu, H., Sperinde, J., Leinonen, M., Huang, W., Weidler, J., Bono, P., Kataja, V., Kokko, R., Turpeenniemi-Hujanen, T., Jyrkkiö, S., Isola, J., Kellokumpu-Lehtinen, P.-L., Paquet, A., Lie, Y., Bates, M.

Volltext

Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients von Collarini, Ellen J, Lee, F. Eun-Hyung, Foord, Orit, Park, Minha, Sperinde, Gizette, Wu, Hai, Harriman, William D, Carroll, Stephen F, Ellsworth, Stote L, Anderson, Larry J, Tripp, Ralph A, Walsh, Edward E, Keyt, Bruce A, Kauvar, Lawrence M

Volltext

Abstract P2-05-21: Predictive value of quantitative HER2 and HER3 levels combined with downstream signaling markers in HER2-positive advanced breast cancer patients treated with la... von Duchnowska, R, Sperinde, J, Czartoryska-Arlukowicz, B, Mysliwiec, P, Winslow, J, Radecka, B, Petropoulos, C, Demlova, R, Orlikowska, M, Kowalczyk, A, Lang, I, Ziólkowska, B, Debska-Szmich, S, Merdalska, M, Grela-Wojewoda, A, Zawrocki, A, Biernat, W, Huang, W, Jassem, J

Volltext

Quantitative Measurements of Tumoral p95HER2 Protein Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab: Independent Validation of the p95HER2 Clinical Cutoff von DUCHNOWSKA, Renata, SPERINDE, Jeff, CZARTORYSKA-ARLUKO-WICZ, Bogumiła, WYSOCKI, Piotr J, FOSZCZYNSKA-KŁODA, Małgorzata, RADECKA, Barbara, LITWINIUK, Maria M, ZOK, Jolanta, WISNIEWSKI, Michał, ZUZIAK, Dorota, BIERNAT, Wojciech, JASSEM, Jacek, CHENNA, Ahmed, HADDAD, Mojgan, PAQUET, Agnes, LIE, Yolanda, WEIDLER, Jodi M, WEIDONG HUANG, WINSLOW, John, JANKOWSKI, Tomasz

Volltext

Anti-tumor effect of CT-322 as an Adnectin inhibitor of vascular endothelial growth factor receptor-2 von Mamluk, Roni, Carvajal, Irvith M., Morse, Brent A., Wong, Henry K, Abramowitz, Janette, Aslanian, Sharon, Lim, Ai-Ching, Gokemeijer, Jochem, Storek, Michael J., Lee, Joonsoo, Gosselin, Michael, Wright, Martin C., Camphausen, Ray T., Wang, Jack, Chen, Yan, Miller, Kathy, Sanders, Kerry, Short, Sarah, Sperinde, Jeff, Prasad, Gargi, Williams, Stephen, Kerbel, Robert S., Ebos, John, Mutsaers, Anthony, Mendlein, John D., Harris, Alan S., Furfine, Eric S.

Volltext